Skip to main content

Table 3 Screening efficacy for supplemental and primary US screening

From: Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis

Author, year Method Cancer detected rate, 1/1000 Recall rate, % Biopsy rate, %
Number 95% CI Number 95% CI Number 95% CI
Supplemental US screening studies
 Tagliafico, 2016 [21] Supplemental US 23/3231 women 7.1(4.6–10.8) 88/3231 2.7(2.2–3.4) 46/3231 1.4(1.1–1.9)
 Kim, 2016 [22] Supplemental US 9/3171 women 2.8(1.4–5.6) 831/3171 26.2(24.7–27.8) 147/3171 4.6(3.9–5.4)
 Weigert, 2015 [26] Supplemental US 24/10282 women 2.3(1.5–3.5) 435/10282 4.2(3.9–4.6)   
 Hwang, 2015 [25] Supplemental US 8/1727 women 4.6(2.2–9.5) 100/1727 5.8(4.8–7.0) 37/1727 2.1(1.5–3.0)
 Moon, 2015 [24] Supplemental US 4/2005 women 2.0(0.6–5.5) 623/2005 31.1(29.1–33.2)   
 Parris, 2013 [28] Supplemental US 10/5519 women 1.8(0.9–3.4) 181/5519 3.3(2.8–3.8) 181/5519 3.3(2.8–3.8)
 Girardi, 2013 [27] Supplemental US 41/22131 women 1.9(1.3–2.5) 422/22131 1.9(1.7–2.1) 422/22131 1.9(1.7–2.1)
 Leong, 2012 [32] Supplemental US 2/141 women 14.2(2.5–55.5) 14/141 9.9(5.7–16.4) 14/141 9.9(5.7–16.4)
 Hooley, 2012 [31] Supplemental US 3/648 women 4.6(1.2–14.7) 153/648 23.6(20.4–27.1) 46/648 7.1(5.3–9.4)
 Corsetti, 2011 [33] Supplemental US 32/7224 examinations 4.4(3.1–6.3) 395/7224 5.5(5.0–6.0) 395/7224 5.5(5.0–6.0)
 Youk, 2011 [34] Supplemental US 10/446 examinations 22.4(11.4–42.2) 51/446 11.4(8.7–14.8) 49/446 11.0(8.3–14.4)
 Brancato, 2007 [36] Supplemental US 2/5227 women 0.4(0.1–1.5) 108/5227 2.1(1.7–2.5) 58/5227 1.1(0.9–1.4)
Joint screening studies
 Dong, 2017 [9] Primary MAM 84/31918 women 2.6(2.1–3.3) 688/31918 2.2(2.0–2.3)   
Primary US 61/31918 women 1.9(1.5–2.5) 450/31918 1.4(1.3–1.5)   
 Ohuchi, 2016 [10] Primary MAM 117/36049 women 3.2(2.7–3.9) 2417/36049 6.7(6.4–7.0)   
Primary US 143/36049 women 4.0(3.4–4.7) 2432/36049 6.7(6.5–7.0)   
 Berg, 2016 [11] Primary MAM 59/7473 examinations 7.9(6.1–10.2) 759/7473 10.2(9.5–10.9) 162/7473 2.2(1.9–2.5)
Primary US 58/7473 examinations 7.8(6.0–10.1) 1070/7473 14.3(13.5–15.1) 499/7473 6.7(6.1–7.3)
 Shen, 2015 [23] Primary MAM 8/6930 examinations 1.2(0.5–2.4) 11/6930 0.2(0.1–0.3) 7/6930 0.1(0.0–0.2)
Primary US 14/6930 examinations 2.0(1.2–3.5) 20/6930 0.3(0.2–0.5) 17/6930 0.2(0.1–0.4)
 Brem, 2015 [39] Primary MAM 82/15318 women 5.4(4.3–6.7) 2301/15318 15.0(14.5–15.6) 586/15318 3.8(3.5–4.1)
Primary US 95/15318 women 6.2(5.0–7.6) 2751/15318 18.0(17.4–18.6) 552/15318 3.6(3.3–3.9)
 Huang, 2012 [30] Primary MAM 28/3028 women 9.2(6.3–13.5) 105/3028 3.5(2.9–4.2)   
Primary US 24/3028 women 7.9(5.2–12.0) 318/3028 10.5(9.4–11.7)   
 Kelly, 2010 [40] Primary MAM 23/4419 women 5.2(3.4–7.9) 59/4419 1.3(1.0–1.7) 59/4419 1.3(1.0–1.7)
Primary US 38/4419 women 8.6(6.2–11.9) 99/4419 2.2(1.8–2.7) 99/4419 2.2(1.8–2.7)
 Wilczek, 2016 [38] Primary MAM 7/1668 women 4.2(1.8–9.0) 23/1668 1.4(0.9–2.1) 11/1668 0.7(0.3–1.2)
Primary US 11/1668 women 6.6(3.5–12.2) 38/1668 2.3(1.6–3.1) 23/1668 1.4(0.9–2.1)
 Venturini, 2013 [29] Primary MAM 12/1666 women 7.2(3.9–12.9) 76/1666 4.6(3.6–5.7) 14/1666 0.8(0.5–1.4)
Primary US 2/835 women 2.4(0.4–9.6) 87/835 10.4(8.5–12.7) 10/835 1.2(0.6–2.3)
 Weinstein, 2009 [35] Primary MAM 7/569 women 12.3(5.4–26.3) 42/569 6.9(5.1–9.3) 20/569 3.3(2.1–5.1)
Primary US 3/567 women 5.3(1.4–16.7) 39/567 6.9(5.0–9.4) 20/567 3.5(2.2–5.5)
 Honjo, 2007 [37] Primary MAM 8/3543 women 2.3(1.1–4.6) 279/3543 7.9(7.0–8.8)   
Primary US 5/3543 women 2.0(0.9–4.3) 165/3543 4.7(4.0–5.4)   
  1. CI Confidential interval;MAM Mammography; US Ultrasonography